First Trust Nasdaq Pharmaceuticals ETF Rating $27.50 +0.15 (+0.53%) Closing price 08/15/2025 03:30 PM EasternExtended Trading$27.50 0.00 (0.00%) As of 08/15/2025 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOptions ChainOwnershipRatingsShort InterestTrendsBuy This Stock First Trust Nasdaq Pharmaceuticals ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.FTXH Aggregate RatingModerate Buy 2.51Holdings in FTXH have an aggregate rating of Moderate Buy based on 430 analyst ratings issued in the past year covering 25 companies (87.3% of the portfolio).FTXH Aggregate Price Target$27.50High Prediction$27.50Average Prediction$27.50Low Prediction$27.50Holdings in FTXH have an aggregate price target of $27.50 and a range of $27.50 to $27.50 covering 25 companies (87.3% of the portfolio).FTXH Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy0 Buy rating(s)Moderate Buy14 Moderate Buy rating(s)Hold9 Hold rating(s)Reduce2 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by First Trust Nasdaq Pharmaceuticals ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 25 FTXH Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings7.98%JNJJohnson & Johnson$176.76+1.2%4.8384 of 5 stars2.65$174.50 -1.3%20Positive News7.20%PFEPfizer$25.16+0.2%4.9607 of 5 stars2.39$28.12 11.8%18Trending NewsAnalyst Revision7.17%ABBVAbbVie$206.65+1.0%4.7267 of 5 stars2.96$214.95 4.0%27Trending NewsAnalyst ForecastInsider TradeAnalyst Revision7.02%MRKMerck & Co., Inc.$84.35+1.9%4.9972 of 5 stars2.35$107.44 27.4%20Positive NewsAnalyst Revision6.16%BMYBristol Myers Squibb$48.45+1.3%4.7218 of 5 stars2.24$56.38 16.4%21Trending NewsAnalyst Revision3.91%GILDGilead Sciences$118.37-0.5%4.8511 of 5 stars2.80$114.82 -3.0%25Positive NewsAnalyst Revision3.90%VTRSViatris$10.61-0.7%2.0503 of 5 stars1.80$10.40 -2.0%5Insider Trade3.86%AMGNAmgen$296.47+2.1%4.6677 of 5 stars2.33$303.76 2.5%21Trending NewsAnalyst Revision3.64%UTHRUnited Therapeutics$313.13+0.3%4.9136 of 5 stars2.69$382.00 22.0%13Positive NewsAnalyst Forecast3.57%BIIBBiogen$138.60+2.7%4.8623 of 5 stars2.34$185.74 34.0%32Positive NewsAnalyst ForecastAnalyst Revision3.54%ZTSZoetis$154.15+0.7%4.922 of 5 stars2.50$202.43 31.3%8Positive News3.25%LLYEli Lilly and Company$701.51+2.5%4.9986 of 5 stars2.71$964.88 37.5%21Trending NewsAnalyst ForecastInsider TradeOptions VolumeAnalyst Revision3.18%JAZZJazz Pharmaceuticals$117.77+0.9%4.443 of 5 stars2.93$181.43 54.1%14Positive News3.13%REGNRegeneron Pharmaceuticals$580.41+2.6%4.837 of 5 stars2.81$829.65 42.9%26News CoveragePositive NewsDividend AnnouncementAnalyst ForecastAnalyst RevisionGap Up2.67%MEDPMedpace$457.85-0.2%4.3123 of 5 stars1.93$406.60 -11.2%14Positive News2.43%CRLCharles River Laboratories International$156.66+0.6%4.7963 of 5 stars2.27$175.69 12.1%15Positive News2.31%ELANElanco Animal Health$17.97-0.2%2.9036 of 5 stars2.88$17.33 -3.5%8News Coverage2.23%ILMNIllumina$100.11+0.0%4.5315 of 5 stars2.25$124.58 24.4%20News CoverageAnalyst Downgrade1.98%EXELExelixis$38.31-0.4%4.8806 of 5 stars2.55$44.06 15.0%22Analyst Forecast1.93%OGNOrganon & Co.$9.43+0.4%4.6979 of 5 stars2.50$18.00 90.9%6Positive News1.66%NBIXNeurocrine Biosciences$132.90+1.2%4.8553 of 5 stars2.86$160.90 21.1%22Positive News1.47%HALOHalozyme Therapeutics$67.27+2.6%4.615 of 5 stars2.18$66.56 -1.1%11Positive NewsInsider Trade1.12%BMRNBioMarin Pharmaceutical$57.54-0.8%4.9979 of 5 stars2.75$93.17 61.9%24Positive News1.00%PRGOPerrigo$22.73-1.3%4.8525 of 5 stars2.40$33.00 45.2%5Analyst Upgrade0.94%ALKSAlkermes$29.05+2.8%4.7928 of 5 stars2.83$41.08 41.4%12News CoveragePositive News This page (NASDAQ:FTXH) was last updated on 8/16/2025 by MarketBeat.com Staff From Our PartnersWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...Porter & Company | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | Sponsored"I'm risking my reputation on this"A massive supply shock is building in the crypto market that could send Bitcoin to $300,000 this year. That...Crypto 101 Media | SponsoredBut this $20 American company could control the secretThe "Impossible" Chip That Runs on Pure Light Google's quantum computer shocked the world... but China DEMO...The Oxford Club | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredCover all your expenses with just $118,000 invested?Generate up to $5,000/month with 10X less money? That's what every financial advisor tells you. But I just ...Investors Alley | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding First Trust Nasdaq Pharmaceuticals ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share First Trust Nasdaq Pharmaceuticals ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access